SCHEMBL28174263

SCHEMBL28174263

COc1cccc(Cc2nncc3cc(SCc4ccccc4)ccc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.47
CYP19A1 P11511 1/20 0.45
CTSB P07858 1/20 0.44
LTB4R Q15722 1/20 0.44
LMNA P02545 4/20 0.43
TP53 P04637 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
HPGD P15428 2/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28173505 0.86 SCN9A (0.54) SCN9ACYP19A1LMNAALDH1A1MAPT
SCHEMBL28173456 0.81 SCN9A (0.55) SCN9ACYP19A1LMNAALDH1A1MAPT
SCHEMBL17824599 0.77 PARP1 (0.54) CTSBCYP2C9CYP2C19CYP3A4
SCHEMBL3894912 0.75 MAOB (0.53) CTSBLMNATP53ALDH1A1MAPT
SCHEMBL28174293 0.74 SCN9A (0.48) SCN9ACYP19A1CTSBALDH1A1MAPT
SCHEMBL28385092 0.74 LMNA (0.54) CTSBLMNATP53ALDH1A1MAPT
SCHEMBL15010833 0.73 SCN9A (0.54) SCN9AALDH1A1MAPTNPC1RAB9A
SCHEMBL28173419 0.73 SCN9A (0.46) SCN9ACYP19A1CTSBTP53ALDH1A1
SCHEMBL28174302 0.72 SCN9A (0.54) SCN9ATP53ALDH1A1MAPTNPC1
SCHEMBL28174297 0.72 SCN9A (0.46) SCN9ACYP19A1CTSBLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207467-A 2, 4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG 癌症研究科技有限公司 2017-09-26 CN disclosed